Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0870
+0.0060 (7.41%)
Sep 8, 2026, 1:35 PM AEST
Genetic Signatures Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 18 | 15 | 83 | 155 | 75 | 166 | |
Market Cap Growth | -71.07% | -81.64% | -46.51% | 105.87% | -54.73% | 5.81% |
Enterprise Value | -3 | -14 | 43 | 137 | 48 | 129 |
Last Close Price | 0.08 | 0.07 | 0.36 | 0.72 | 0.51 | 1.13 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | - | - | - | 54.30 |
Forward PE | - | 85.15 | 85.15 | 85.15 | 85.15 | 85.15 |
PS Ratio | 0.95 | 0.79 | 4.20 | 11.26 | 3.50 | 4.69 |
PB Ratio | 0.52 | 0.43 | 1.66 | 2.54 | 1.75 | 3.04 |
P/TBV Ratio | 0.52 | 0.43 | 1.66 | 2.83 | 2.01 | 3.13 |
P/FCF Ratio | - | - | - | - | - | 20.56 |
P/OCF Ratio | - | - | - | - | - | 16.96 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | - | - | 2.18 | 9.94 | 2.25 | 3.64 |
EV/EBITDA Ratio | - | - | - | - | - | 30.00 |
EV/EBIT Ratio | - | - | - | - | - | 42.56 |
EV/FCF Ratio | - | - | - | - | - | 15.95 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | - | 0.00 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.01 |
Debt / FCF Ratio | - | - | - | - | - | 0.00 |
Net Debt / Equity Ratio | -0.61 | -0.61 | -0.61 | -0.57 | -0.38 | -0.67 |
Net Debt / EBITDA Ratio | 1.93 | 1.93 | 2.41 | 2.12 | 1.25 | -8.57 |
Net Debt / FCF Ratio | 2.47 | 2.47 | 2.36 | 2.90 | 1.14 | -4.55 |
Asset Turnover | 0.42 | 0.42 | 0.32 | 0.24 | 0.40 | 0.62 |
Inventory Turnover | 1.40 | 1.40 | 1.17 | 1.02 | 1.25 | 1.22 |
Quick Ratio | 10.80 | 10.80 | 9.49 | 8.76 | 4.55 | 8.54 |
Current Ratio | 13.10 | 13.10 | 11.70 | 10.04 | 5.99 | 10.66 |
Return on Equity (ROE) | -32.64% | -32.64% | -36.16% | -34.34% | -28.76% | 5.88% |
Return on Assets (ROA) | -17.27% | -17.27% | -15.00% | -19.69% | -16.78% | 3.33% |
Return on Capital Employed (ROCE) | -36.00% | -36.00% | -28.90% | -29.50% | -33.90% | 5.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -76.13% | -92.03% | -24.25% | -11.52% | -18.66% | 1.84% |
FCF Yield | -47.93% | -57.94% | -15.61% | -7.81% | -19.10% | 4.87% |
Buyback Yield / Dilution | -0.19% | -0.19% | -37.18% | -15.25% | 1.40% | 0.16% |